MetaVia Inc. (MTVA) vs Tvardi Therapeutics, Inc. (TVRD)
A side-by-side comparison of MetaVia Inc. and Tvardi Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MTVA
MetaVia Inc.
$1.50HealthcareDelayed quote: Oct 6, 2026, 2:18 PM EDT
TVRD
Tvardi Therapeutics, Inc.
$1.11HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — MTVA vs TVRD
growth of $100 · dividends reinvested · last 1yMTVA -89.9% (-89.9%/yr)TVRD -76.7% (-76.7%/yr)TVRD compounded faster over this window
MTVA TVRD
MTVA vs TVRD: by the numbers
- •TVRD is the larger company ($10M vs $10M market cap).
Metrics side by side
Valuation
| Metric | MTVA | TVRD |
|---|---|---|
| P/B ratio | 1.45 | 1.24 |
Profitability
| Metric | MTVA | TVRD |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -211.76% | -310.94% |
| ROIC | -215.61% | -323.71% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.